A Case Study of Gastric Adenocarcinoma and Squamous Cell Carcinoma of the Cervix
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 15, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Traditional Chinese Medicine in Regulating Tumor Microenvironment
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 10, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Primary Epithelioid Angiosarcoma of the Jejunal Mesentery Causing Abdominal Bleeding: Case Report and Literature Review
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 10, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
MAP2K1 K57N Conferred an Acquired Resistance to Furmonertinib, Dabrafenib and Trametinib Combined Therapy in Advanced Lung Adenocarcinoma with EGFR Mutation and BRAF V600E
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 9, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
miR-31 Modulates Liver Cancer HepG2 Cell Apoptosis and Invasion via ROCK1/F-Actin Pathways [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 5, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Antitumor Effect of Triptolide in T-Cell Lymphoblastic Lymphoma by Inhibiting Cell Viability, Invasion, and Epithelial –Mesenchymal Transition via Regulating the PI3K/AKT/mTOR Pathway [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 4, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
MicroRNA-155-3p Promotes Breast Cancer Progression Through Down-Regulating CADM1 [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 4, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Effects of miR-330-3p on Invasion, Migration and EMT of Gastric Cancer Cells by Targeting PRRX1-Mediated Wnt/ β-Catenin Signaling Pathway [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 4, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
TNF α Promotes Glioblastoma A172 Cell Mitochondrial Apoptosis via Augmenting Mitochondrial Fission and Repression of MAPK–ERK–YAP Signaling Pathways [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 3, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Long-Term Follow-Up of Combination Therapy with Sintilimab and Anlotinib in Gallbladder Follicular Dendritic Cell Sarcoma: A Rare Case Report
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 3, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Hsa_circRNA_000166 Promotes Cell Proliferation, Migration and Invasion by Regulating miR-330-5p/ELK1 in Colon Cancer [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 2, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Overexpression of Mst1 Reduces Gastric Cancer Cell Viability by Repressing the AMPK-Sirt3 Pathway and Activating Mitochondrial Fission [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 2, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Circular RNA Hsa_circ_0023404 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer by Regulating miR-217/ZEB1 Axis [Retraction]
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - April 2, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Efficacy and Safety of the MDM2 –p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - March 29, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
A Novel Intergenic Region (chr2: 30,316,870)-ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report
(Source: OncoTargets and Therapy)
Source: OncoTargets and Therapy - March 26, 2024 Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
